246 related articles for article (PubMed ID: 21671465)
1. Totally implantable central venous access ports. Analysis of 700 cases.
Barbetakis N; Asteriou C; Kleontas A; Tsilikas C
J Surg Oncol; 2011 Nov; 104(6):654-6. PubMed ID: 21671465
[TBL] [Abstract][Full Text] [Related]
2. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
[TBL] [Abstract][Full Text] [Related]
3. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
[TBL] [Abstract][Full Text] [Related]
4. [Implantable catheter systems. Experiences with 1000 patients with central venous ports].
Kock HJ; Krause U; Pietsch M; Rasfeld S; Walz MK
Dtsch Med Wochenschr; 1996 Jan; 121(3):47-51. PubMed ID: 8565809
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
[TBL] [Abstract][Full Text] [Related]
6. Totally implantable femoral vein catheters in cancer patients.
Wolosker N; Yazbek G; Munia MA; Zerati AE; Langer M; Nishinari K
Eur J Surg Oncol; 2004 Sep; 30(7):771-5. PubMed ID: 15296992
[TBL] [Abstract][Full Text] [Related]
7. Long-term complications in totally implantable venous access devices: randomized study comparing subclavian and internal jugular vein puncture.
Ribeiro RC; Abib SC; Aguiar AS; Schettini ST
Pediatr Blood Cancer; 2012 Feb; 58(2):274-7. PubMed ID: 21674765
[TBL] [Abstract][Full Text] [Related]
8. Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms.
Puig-la Calle J; López Sánchez S; Piedrafita Serra E; Allende Honorato L; Artigas Raventós V; Puig la Calle J
J Surg Oncol; 1996 Aug; 62(4):273-8. PubMed ID: 8691841
[TBL] [Abstract][Full Text] [Related]
9. Venous access ports: frequency and management of complications in oncology patients.
Jordan K; Behlendorf T; Surov A; Kegel T; Maher G; Wolf HH
Onkologie; 2008 Jul; 31(7):404-10. PubMed ID: 18596390
[TBL] [Abstract][Full Text] [Related]
10. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
Koonings PP; Given FT
J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
[TBL] [Abstract][Full Text] [Related]
11. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
[TBL] [Abstract][Full Text] [Related]
12. Totally implantable central venous access devices in adult oncological patients.
Florio G; Del Papa M; Mari A; Carnì D
Chir Ital; 2008; 60(5):697-702. PubMed ID: 19062492
[TBL] [Abstract][Full Text] [Related]
13. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
[TBL] [Abstract][Full Text] [Related]
14. Totally implantable venous catheters for chemotherapy: experience in 500 patients.
Wolosker N; Yazbek G; Nishinari K; Malavolta LC; Munia MA; Langer M; Zerati AE
Sao Paulo Med J; 2004 Jul; 122(4):147-51. PubMed ID: 15543368
[TBL] [Abstract][Full Text] [Related]
15. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
[TBL] [Abstract][Full Text] [Related]
16. [Totally implantable vascular reservoir for chemotherapy: initial experience].
Cutait R; Averbach M; Borges JL; Carone E; Correa PA
AMB Rev Assoc Med Bras; 1990; 36(2):97-9. PubMed ID: 1965673
[TBL] [Abstract][Full Text] [Related]
17. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.
Bassi KK; Giri AK; Pattanayak M; Abraham SW; Pandey KK
Indian J Cancer; 2012; 49(1):114-8. PubMed ID: 22842178
[TBL] [Abstract][Full Text] [Related]
18. A peripherally implanted permanent central venous access device.
Morris P; Buller R; Kendall S; Anderson B
Obstet Gynecol; 1991 Dec; 78(6):1138-42. PubMed ID: 1945224
[TBL] [Abstract][Full Text] [Related]
19. [Implantable devices for central venous access in cancer patients. Our experience in 217 cases].
Torramadé J; Hernández JL; Cienfuegos JA; Albiach M; Pardo F; Benito C; González J; Voltas J
Med Clin (Barc); 1992 May; 98(19):731-3. PubMed ID: 1608278
[TBL] [Abstract][Full Text] [Related]
20. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
Pittiruti M; Hamilton H; Biffi R; MacFie J; Pertkiewicz M;
Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]